Cymabay Therapeu Price on June 8, 2023
CBAYDelisted Stock | USD 11.83 0.27 2.34% |
If you're considering investing in Cymabay Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cymabay Therapeu stands at 11.83, as last reported on the 2nd of December, with the highest price reaching 12.43 and the lowest price hitting 11.52 during the day. We have found twenty-nine technical indicators for Cymabay Therapeu, which you can use to evaluate the volatility of the firm. Please confirm Cymabay Therapeu's Downside Deviation of 3.68, risk adjusted performance of 0.0606, and Mean Deviation of 3.0 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cymabay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cymabay |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CBAY |
Based on monthly moving average Cymabay Therapeu is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cymabay Therapeu by adding Cymabay Therapeu to a well-diversified portfolio.
Related Headline
Pliant Therapeutics Headline on 8th of June 2023
Acquisition by Knobil Katharine of 14000 shares of Pliant Th... by Knobil Katharine
Filed transaction by Pliant Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Cymabay Therapeu Valuation on June 8, 2023
It is possible to determine the worth of Cymabay Therapeu on a given historical date. On June 8, 2023 Cymabay was worth 9.39 at the beginning of the trading date compared to the closed value of 9.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cymabay Therapeu stock. Still, in general, we apply an absolute valuation method to find Cymabay Therapeu's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cymabay Therapeu where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cymabay Therapeu's related companies.
Open | High | Low | Close | Volume | |
9.46 | 9.63 | 9.36 | 9.42 | 716,250 | |
06/08/2023 | 9.39 | 9.51 | 9.29 | 9.31 | 673,597 |
9.30 | 9.43 | 9.10 | 9.16 | 1,091,700 |
Backtest Cymabay Therapeu | | | Cymabay Therapeu History | | | Cymabay Therapeu Valuation | Previous | Next |
Cymabay Therapeu Trading Date Momentum on June 8, 2023
On June 09 2023 Cymabay Therapeu was traded for 9.16 at the closing time. The top price for the day was 9.43 and the lowest listed price was 9.10 . The trading volume for the day was 1.1 M. The trading history from June 9, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.61% . The overall trading delta against the current closing price is 12.89% . |
Cymabay Therapeu Fundamentals Correlations and Trends
By evaluating Cymabay Therapeu's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cymabay Therapeu's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cymabay financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cymabay Therapeu Stock history
Cymabay Therapeu investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cymabay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cymabay Therapeu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cymabay Therapeu stock prices may prove useful in developing a viable investing in Cymabay Therapeu
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Cymabay Therapeu Stock Technical Analysis
Cymabay Therapeu technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Cymabay Therapeu Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Cymabay Therapeu cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cymabay Therapeu December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Cymabay Therapeu stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cymabay Therapeu shares will generate the highest return on investment. By undertsting and applying Cymabay Therapeu stock market strength indicators, traders can identify Cymabay Therapeu entry and exit signals to maximize returns
Cymabay Therapeu Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cymabay Therapeu's price direction in advance. Along with the technical and fundamental analysis of Cymabay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cymabay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0606 | |||
Jensen Alpha | 0.3487 | |||
Total Risk Alpha | (0.59) | |||
Sortino Ratio | 0.0701 | |||
Treynor Ratio | 1.33 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |